123 related articles for article (PubMed ID: 15115957)
1. Ketorolac pharmacokinetics in experimental cirrhosis by bile duct ligation in the rat.
Rivera-Espinosa L; Muriel P; Ordaz Gallo M; Pérez-Urizar J; Palma-Aguirre A; Castañeda-Hernández G
Ann Hepatol; 2003; 2(4):175-81. PubMed ID: 15115957
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic bile duct obstruction and LPS upon targeting of naproxen to the liver using naproxen-albumin conjugate.
Albrecht C; Melgert BN; Reichen J; Poelstra K; Meijer DK
J Drug Target; 1998; 6(2):105-17. PubMed ID: 9886235
[TBL] [Abstract][Full Text] [Related]
3. [Prolonged angiotensin-(1-7) infusion inhibits hepatic fibrosis in rats with bile duct ligation].
Li X; Ning Z; Luo W; Zhang W; Yu C
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):944-7. PubMed ID: 22820573
[TBL] [Abstract][Full Text] [Related]
4. Rat renal function four days after bile-duct ligation: effects of indomethacin and vasoactive agents.
Monasterolo LA; Ochoa JE; Elías MM
Ren Fail; 2002 Mar; 24(2):111-26. PubMed ID: 12071586
[TBL] [Abstract][Full Text] [Related]
5. Effects of nebivolol on liver fibrosis induced by bile duct ligation in Wistar rats.
Teixeira C; Franco E; Oliveira PA; Colaço B; Gama A; Carrola J; Pires CA; Colaço A; Pires MJ
In Vivo; 2013; 27(5):635-40. PubMed ID: 23988899
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-γ activation attenuates motor and cognition impairments induced by bile duct ligation in a rat model of hepatic cirrhosis.
Aghaei I; Shabani M; Doustar N; Nazeri M; Dehpour A
Pharmacol Biochem Behav; 2014 May; 120():133-9. PubMed ID: 24631483
[TBL] [Abstract][Full Text] [Related]
7. Changes in liver and plasma acetylcholinesterase in rats with cirrhosis induced by bile duct ligation.
García-Ayllón MS; Silveyra MX; Candela A; Compañ A; Clària J; Jover R; Pérez-Mateo M; Felipo V; Martínez S; Galcerán J; Sáez-Valero J
Hepatology; 2006 Mar; 43(3):444-53. PubMed ID: 16496349
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of ketorolac after intravenous and oral single dose administration in dogs.
Pasloske K; Renaud R; Burger J; Conlon P
J Vet Pharmacol Ther; 1999 Oct; 22(5):314-9. PubMed ID: 10597535
[TBL] [Abstract][Full Text] [Related]
9. Chronic bile duct obstruction induces changes in plasma and hepatic levels of cytokines and nitric oxide in the rat.
Fernández-Martínez E; Pérez-Alvarez V; Tsutsumi V; Shibayama M; Muriel P
Exp Toxicol Pathol; 2006 Aug; 58(1):49-58. PubMed ID: 16617007
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats.
Zhen YZ; Li NR; He HW; Zhao SS; Zhang GL; Hao XF; Shao RG
World J Gastroenterol; 2015 Jun; 21(23):7155-64. PubMed ID: 26109801
[TBL] [Abstract][Full Text] [Related]
11. Review of experimental models for inducing hepatic cirrhosis by bile duct ligation and carbon tetrachloride injection.
Marques TG; Chaib E; da Fonseca JH; Lourenço AC; Silva FD; Ribeiro MA; Galvão FH; D'Albuquerque LA
Acta Cir Bras; 2012 Aug; 27(8):589-94. PubMed ID: 22850713
[TBL] [Abstract][Full Text] [Related]
12. Enantioselective disposition after single dose I.V administration of ketorolac in male Wistar rats.
Dubey SK; Saha RN; Mittapelly N; Anand A
Drug Res (Stuttg); 2013 Jan; 63(1):34-7. PubMed ID: 23447046
[TBL] [Abstract][Full Text] [Related]
13. The differences in selected biochemical markers and histological findings after bile duct ligation in male and female rats.
Zivna H; Zivny P; Palicka V; Nozicka J
Adv Clin Path; 2001 Oct; 5(4):147-53. PubMed ID: 17582939
[TBL] [Abstract][Full Text] [Related]
14. [Inhibitory effect of angiotensin blockade on hepatic fibrosis in common bile duct-ligated rats].
Park DH; Baik SK; Choi YH; Kim MY; Rhim DW; Kim JW; Kwon SO; Cho MY; Kim CH; Ahn SC
Korean J Hepatol; 2007 Mar; 13(1):61-9. PubMed ID: 17380076
[TBL] [Abstract][Full Text] [Related]
15. Dihydropyrimidine dehydrogenase activity and fluorouracil pharmacokinetics with liver damage induced by bile duct ligation in rats.
Tateishi T; Watanabe M; Nakura H; Tanaka M; Kumai T; Sakata SF; Tamaki N; Ogura K; Nishiyama T; Watabe T; Kobayashi S
Drug Metab Dispos; 1999 Jun; 27(6):651-4. PubMed ID: 10348793
[TBL] [Abstract][Full Text] [Related]
16. Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats.
Mahmoud MF; Swefy SE; Hasan RA; Ibrahim A
Eur J Pharmacol; 2014 Nov; 742():118-24. PubMed ID: 25179573
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the 13C-octanoate breath test as a surrogate marker of liver damage in animal models.
Shalev T; Aeed H; Sorin V; Shahmurov M; Didkovsky E; Ilan Y; Avni Y; Shirin H
Dig Dis Sci; 2010 Jun; 55(6):1589-98. PubMed ID: 19731033
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of ketorolac loaded to polyethylcyanoacrylate nanoparticles using UPLC MS/MS for its determination in rats.
Radwan MA; AlQuadeib BT; Aloudah NM; Aboul Enein HY
Int J Pharm; 2010 Sep; 397(1-2):173-8. PubMed ID: 20600724
[TBL] [Abstract][Full Text] [Related]
19. The effects of pegylated interferon alpha 2b on bile-duct ligation induced liver fibrosis in rats.
Canbakan B; Akin H; Tahan G; Tarcin O; Eren F; Atug O; Tahan V; Imeryuz N; Yapicier O; Avsar E; Tozun N
Ann Hepatol; 2009; 8(3):234-40. PubMed ID: 19841503
[TBL] [Abstract][Full Text] [Related]
20. HIF-1 α as a Key Factor in Bile Duct Ligation-Induced Liver Fibrosis in Rats.
Moczydlowska J; Miltyk W; Hermanowicz A; Lebensztejn DM; Palka JA; Debek W
J Invest Surg; 2017 Feb; 30(1):41-46. PubMed ID: 27260943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
